Louvain Center for Toxicology and Applied Pharmacology (LTAP),
Institut de Recherche Expérimentale et Clinique (IREC),
Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et Clinique (IREC)
Teresinha Leal has not added Biography.
If you are Teresinha Leal and would like to personalize this page please email our Author Liaison for assistance.
Modified method to measure nasal potential difference.
Clinical chemistry and laboratory medicine Jan, 2003 | Pubmed ID: 12636051
Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion.
Antimicrobial agents and chemotherapy Jun, 2003 | Pubmed ID: 12760889
The role of epithelial P2Y2 and P2Y4 receptors in the regulation of intestinal chloride secretion.
British journal of pharmacology Oct, 2005 | Pubmed ID: 16056234
Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Dec, 2006 | Pubmed ID: 16790367
Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice.
Respiratory research Oct, 2006 | Pubmed ID: 17064416
Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney.
Journal of the American Society of Nephrology : JASN Mar, 2007 | Pubmed ID: 17287432
An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
Clinical biochemistry May, 2007 | Pubmed ID: 17316592
Effect of continuous positive airway pressure combined to nebulization on lung deposition measured by urinary excretion of amikacin.
Respiratory medicine Oct, 2007 | Pubmed ID: 17628465
Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis.
American journal of respiratory and critical care medicine Mar, 2008 | Pubmed ID: 18006891
Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis.
Clinical chemistry Feb, 2008 | Pubmed ID: 18089657
Airway ion transport impacts on disease presentation and severity in cystic fibrosis.
Clinical biochemistry Jul, 2008 | Pubmed ID: 18424267
Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.
American journal of respiratory cell and molecular biology Nov, 2009 | Pubmed ID: 19244203
Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice.
American journal of respiratory and critical care medicine Jun, 2009 | Pubmed ID: 19299496
Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society May, 2009 | Pubmed ID: 19345617
Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice.
The European respiratory journal Jan, 2011 | Pubmed ID: 20562123
Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations.
Journal of aerosol medicine and pulmonary drug delivery Dec, 2010 | Pubmed ID: 20958144
Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent's disease.
Pflugers Archiv : European journal of physiology Dec, 2011 | Pubmed ID: 21927812
A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential difference.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society May, 2012 | Pubmed ID: 22281182
Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Jul, 2012 | Pubmed ID: 22503062
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
Clinical biochemistry Oct, 2012 | Pubmed ID: 22698459
PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.
Frontiers in pharmacology , 2012 | Pubmed ID: 23024633
Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosis.
PloS one , 2013 | Pubmed ID: 23734196
Clinical and morphological characteristics of sporadic genetically determined pancreatitis as compared to idiopathic pancreatitis: higher risk of pancreatic cancer in CFTR variants.
Digestion , 2013 | Pubmed ID: 23751316
Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Jan, 2014 | Pubmed ID: 24022019
Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice.
PloS one , 2013 | Pubmed ID: 24204804
Lung inflammation in cystic fibrosis: pathogenesis and novel therapies.
Clinical biochemistry May, 2014 | Pubmed ID: 24380764
Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patients.
PloS one , 2014 | Pubmed ID: 25503271
Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice.
Biology open Jun, 2015 | Pubmed ID: 26092868
Identification and frequencies of cystic fibrosis mutations in central Argentina.
Clinical biochemistry Jan, 2016 | Pubmed ID: 26500004
Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency.
American journal of respiratory and critical care medicine May, 2016 | Pubmed ID: 26694899
Strategies in early clinical development for the treatment of basic defects of cystic fibrosis.
Expert opinion on investigational drugs , 2016 | Pubmed ID: 26878157
Influence of Tracheostomy on Lung Deposition in Spontaneously Breathing Patients.
Journal of aerosol medicine and pulmonary drug delivery Oct, 2016 | Pubmed ID: 26907544
HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients.
Future microbiology , 2016 | Pubmed ID: 26934639
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives.
Clinical pharmacology : advances and applications , 2016 | Pubmed ID: 27703398
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium.
Frontiers in immunology , 2016 | Pubmed ID: 27895643
Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms.
Clinical science (London, England : 1979) Jun, 2017 | Pubmed ID: 28196856
Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy.
International journal of pharmaceutics May, 2017 | Pubmed ID: 28356227
In Vitro and In Vivo Evaluation of the Combination of Oscillating Positive Expiratory Pressure and Nebulization: A Randomized Cross-Over Study.
Archivos de bronconeumologia Dec, 2017 | Pubmed ID: 28558927
In Vitro and In Vivo Comparison of Two Nebulizers Used for Inhaled Pentamidine Delivery.
Archivos de bronconeumologia Dec, 2017 | Pubmed ID: 28583257
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Mar, 2018 | Pubmed ID: 29292091
Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.
Clinical science (London, England : 1979) Jun, 2018 | Pubmed ID: 29871879
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados